% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Vollmuth:909633,
author = {Vollmuth, Philipp and Foltyn, Martha and Huang, Raymond Y
and Galldiks, Norbert and Petersen, Jens and Isensee, Fabian
and van den Bent, Martin J and Barkhof, Frederik and Park,
Ji Eun and Park, Yae Won and Ahn, Sung Soo and Brugnara,
Gianluca and Meredig, Hagen and Jain, Rajan and Smits,
Marion and Pope, Whitney B and Maier-Hein, Klaus and Weller,
Michael and Wen, Patrick Y and Wick, Wolfgang and Bendszus,
Martin},
title = {{A}rtificial intelligence ({AI})-based decision support
improves reproducibility of tumor response assessment in
neuro-oncology: {A}n international multi-reader study},
journal = {Neuro-Oncology},
volume = {25},
number = {3},
issn = {1522-8517},
address = {Oxford},
publisher = {Oxford Univ. Press},
reportid = {FZJ-2022-03304},
pages = {533–543},
year = {2023},
abstract = {Background: To assess whether AI-based decision support
allows more reproducible and standardized assessment of
treatment response on MRI in neuro-oncology as compared to
manual 2-dimensional measurements of tumor burden using the
RANO criteria.Methods: A series of 30 patients (15
lower-grade gliomas, 15 glioblastoma) with availability of
consecutive MRI scans was selected. The time to progression
(TTP) on MRI was separately evaluated for each patient by 15
investigators over two rounds. In the 1 st round the TTP was
evaluated based on the RANO-criteria, whereas in the 2 nd
round the TTP was evaluated by incorporating additional
information from AI-enhanced MRI-sequences depicting the
longitudinal changes in tumor volumes. The agreement of the
TTP-measurements between investigators was evaluated using
concordance correlation coefficients (CCC) with confidence
intervals (CI) and p-values obtained using bootstrap
resampling.Results: The CCC of TTP-measurements between
investigators was 0.77 $(95\%CI=0.69,0.88)$ with RANO alone
and increased to 0.91 $(95\%CI=0.82,0.95)$ with AI-based
decision support (p=0.005). This effect was significantly
greater (p=0.008) for patients with lower-grade gliomas
(CCC=0.70 $[95\%CI=0.56,0.85]$ without vs. 0.90
$[95\%CI=0.76,0.95]$ with AI-based decision support) as
compared to glioblastoma (CCC=0.83 $[95\%CI=0.75,0.92]$
without vs. 0.86 $[95\%CI=0.78,0.93]$ with AI-based decision
support). Investigators with less years of experience judged
the AI-based decision as more helpful (p=0.02).Conclusions:
AI-based decision support has the potential to yield more
reproducible and standardized assessment of treatment
response in neuro-oncology as compared to manual
2-dimensional measurements of tumor burden, particularly in
patients with lower-grade gliomas. A fully-functional
version of this AI-based processing pipeline is provided as
open-source
(https://github.com/NeuroAI-HD/HD-GLIO-XNAT).Keywords:
AI-based decision support; RANO; tumor response assessment;
tumor volumetry.},
cin = {INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406},
pnm = {5252 - Brain Dysfunction and Plasticity (POF4-525)},
pid = {G:(DE-HGF)POF4-5252},
typ = {PUB:(DE-HGF)16},
pubmed = {35917833},
UT = {WOS:000843014300001},
doi = {10.1093/neuonc/noac189},
url = {https://juser.fz-juelich.de/record/909633},
}